Share this
Oyster Point Pharma to Be Acquired by Viatris
November 9, 2022
Vaxcyte – $690 Million Public Offering
October 31, 2022
Neurocrine Partners With Takeda to Address Psychiatric Disorders
June 29, 2020
Cooley Advises on Series of Life Sciences IPOs
Zymeworks, Verona, UroGen and Biohaven IPOs highlight core strengths across the sector • May 30, 2017